Anteris Technologies Global Corp. (AVR), a global medical technology company dedicated to advancing cardiac care, is approaching a clinical milestone in the upcoming quarter that warrants attention.
The company's lead product is DurAVR Transcatheter Heart Valve, designed to treat aortic stenosis, a potentially life-threatening condition caused by the narrowing of the aortic valve. This narrowing restricts blood flow from the heart to the body's main artery, the aorta, and subsequently to the rest of the body. Patients with severe aortic stenosis have a 50% risk of dying within 2 years.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.